Procter & Gamble Health Ltd - 500126 - Disclosure Of Voting Results Of The Postal Ballot Process
We are enclosing herewith following documents: 1. Proceedings of the Postal Ballot 2. Voting results in respect of the Postal Ballot process, as required under Regulation 44 of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015; and 3. Scrutinizers Report Kindly take the above on record and oblige
Two vaccines, Merck drug cleared for emergency use amid Omicron rise
150 mn doses of Corbevax, Covovax expected monthly from March
Japan health panel approves Merck's oral COVID treatment
"I'm convinced the distribution of this drug is a major step forward for our nation's COVID-19 handling," health minister Shigeyuki Goto told reporters after the decision.
Covid-19: UK orders millions more antiviral pills as Omicron spreads
Britain has secured an additional 1.75 million courses of Merck's drug, molnupiravir, and an additional 2.5 million courses of Pfizer's paxlovid
The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival
Ramp-up meant scouting for raw materials, buying equipment, retrofitting plants
Wall St bounces back after rout spurred by inflation, Omicron risks
Merck & Co Inc gained 1.8% after a panel of advisers to the U.S. Food and Drug Administration narrowly voted to recommend the agency authorize the drugmaker's antiviral pill to treat COVID-19 Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to regulation 39(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015,we hereby inform you regarding issue of duplicate share certificate(s) to the shareholder(s) of the Company, on November 30,2021. We request you to take the same on record and acknowledge the receipt. Procter & Gamble Health Ltd - 500126 - Announcement- Addendum To Postal Ballot Notice And Form
We would like to submit an addendum to the notice of the Postal Ballot along with Postal Ballot form with respect to the Company's proposal for seeking approval of the Members for appointment of Mr. Subramanian Madhavan (DIN 06451889) as a Non-Executive Independent Director of the Company for a period of five years (Ordinary Resolution). Procter & Gamble Health Ltd - 500126 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
We would like to submit the notice of the Postal Ballot along with Postal Ballot form with respect to Company''s proposal for seeking members'' approval for the below resolution: Appointment of Mr. Subramanian Madhavan (DIN 06451889) as a Non-Executive Independent Director of the Company for a period of five years (Ordinary Resolution). Kindly take the above on record and acknowledge the receipt.
Merck says its antiviral pill less effective in final analysis
The lower efficacy is a disappointment for the drug, known as molnupiravir, which health officials around the world are counting on as a critical tool to save lives and reduce the burden on hospitals.